Search research articles
Contact Us
Filters
Showing results (181-190 of 213) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2014
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer
Amir Goldkorn, Benjamin Ely, David I Quinn, et al.
International Journal of Cancer
|
September 16, 2014
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial
Amir Goldkorn, Benjamin Ely, Catherine M Tangen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
The quality of early relational health modifies the effect of early life stress on child emerging psychopathology
Jennifer Warmingham, Andréane Lavallée, Paul Curtin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
The Journal of Urology
|
September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop
Chana Weinstock, Daniel Suzman, Paul Kluetz, et al.
The New England Journal of Medicine
|
April 5, 2013
Intermittent versus continuous androgen deprivation in prostate cancer
Maha Hussain, Catherine M Tangen, Donna L Berry, et al.
Pediatric Research
|
April 21, 2022
Pandemic beyond the virus: maternal COVID-related postnatal stress is associated with infant temperament
Catherine Bianco, Ayesha Sania, Margaret H Kyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 213) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2014
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer
Amir Goldkorn, Benjamin Ely, David I Quinn, et al.
International Journal of Cancer
|
September 16, 2014
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial
Amir Goldkorn, Benjamin Ely, Catherine M Tangen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
The quality of early relational health modifies the effect of early life stress on child emerging psychopathology
Jennifer Warmingham, Andréane Lavallée, Paul Curtin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
The Journal of Urology
|
September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop
Chana Weinstock, Daniel Suzman, Paul Kluetz, et al.
The New England Journal of Medicine
|
April 5, 2013
Intermittent versus continuous androgen deprivation in prostate cancer
Maha Hussain, Catherine M Tangen, Donna L Berry, et al.
Pediatric Research
|
April 21, 2022
Pandemic beyond the virus: maternal COVID-related postnatal stress is associated with infant temperament
Catherine Bianco, Ayesha Sania, Margaret H Kyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Page
of 22